Multicenter Postmarket Surveillance Registry Evaluating Performance and Long Term Safety of the Presillion Stent

CompletedOBSERVATIONAL
Enrollment

318

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

May 31, 2011

Conditions
Coronary Arteriosclerosis
Interventions
DEVICE

Presillion stent

Centers will use commercially available Presillion Stents as recommended according to the Instruction For Use (IFU).

Trial Locations (13)

25198

Hospital Universitario Arnau de Vilanova, Lleida

33006

Hospital Universitario Central de Asturias, Oviedo

39008

Hospital Universitario Marques de Valdecilla, Santander

2805-951

Hospital Garcia Da Orta, Almada

2799-523

Hospital de Santa Cruz, Lisbon

4200-319

Hospital Sao Joao, Porto

5000 - 508

Centro Hospitalar Vila Real, Vila Real

02006

Complejo Hospitalario Universitario de Albacete, Albacete

08916

Hospital Germans Trias I Pujol, Badalona

08022

Centro Medico Teknon, Barcelona

08025

Hospital de La Santa Creu I Sant Pau, Barcelona

08907

Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat

08195

Capio Hospital General de Cataluña, Sant Cugat del Vallès

Sponsors
All Listed Sponsors
lead

Johnson and Johnson, S.A.

INDUSTRY